Hospital-Acquired Bacterial Pneumonia/ Ventilator-Associated Bacterial Pneumonia
Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infections (HAIs) and hospital-acquired infections. It is often seen in patients admitted to ICU wards.
About 1 in 10 people admitted to hospitals contract HAIs. The infection causes a financial burden on patients and is a significant cause of morbidity and mortality.
DelveInsight, through its newsletter series, brings to light an overview of the infection, underlying causes, etiology, and symptoms.
The newsletter provides an overview of the prevalence of the disease, the treatment market, and the emerging therapies in the market, transforming the HABP/VABP market landscape.
Download the newsletter by filling up the form and gain access to deep and rich insights into the HABP/VABP market, treatment guidelines, and research taking place in the domain.
Gain access to analytical information related to Life Science vertical directly delivered to your inbox by joining DelveInsight's emailer list and gain a competitive edge.
Stay tuned for more.
Know more about What's covered:
- Indication overview
- Epidemiological trends
- Treatment approaches
- Key Companies
- Pipeline drugs
- Collaborations and deals in the domain
- R&D in the field
- Top conferences
- Support from International organizations
